1. Clinical Overview
Betamethasone is a potent synthetic glucocorticoid (corticosteroid) with high anti-inflammatory, immunosuppressive, antipruritic, and vasoconstrictive properties. In the 0.1% w/w topical formulation, it is primarily used for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It acts by inducing phospholipase A2 inhibitory proteins (lipocortins), which control the biosynthesis of potent mediators of inflammation like prostaglandins and leukotrienes.
| Onset | Duration | Bioavailability |
|---|---|---|
| Clinical improvement in pruritus and erythema is typically observed within 24-48 hours of topical application. | The anti-inflammatory effect persists for several hours after application, necessitating application 1-2 times daily. | Topical bioavailability is variable (1-5%) depending on the vehicle, skin integrity, and site of application. Systemic absorption is minimal when used on intact skin for limited duration and area. |
2. Mechanism of Action
Betamethasone binds to specific intracellular glucocorticoid receptors. The activated receptor complex translocates to the cell nucleus, binds to glucocorticoid response elements (GREs) in DNA, and modulates gene transcription. This leads to the synthesis of anti-inflammatory proteins (lipocortins) and inhibition of genes encoding for pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNF-α). It also inhibits phospholipase A2, reducing arachidonic acid release and subsequent prostaglandin and leukotriene synthesis.
3. Indications & Uses
- Inflammatory dermatoses (e.g., psoriasis, eczema, atopic dermatitis)
- Pruritic manifestations of corticosteroid-responsive dermatoses
- Contact dermatitis (allergic and irritant)
- Seborrheic dermatitis
- Lichen planus
- Discoid lupus erythematosus (cutaneous lesions)
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area 1 to 2 times daily. For most conditions, once-daily application is sufficient. Therapy should be limited to 2-4 weeks. For chronic conditions like psoriasis, intermittent therapy is recommended.
Administration: Wash and dry the affected area gently. Apply a thin layer and rub in lightly until it disappears. Do not bandage or cover the area unless directed by a physician (occlusive dressing increases absorption and risk of side effects). Wash hands after application unless hands are the treatment site. Avoid contact with eyes, mouth, nose, and mucous membranes.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation
- Skin dryness
- Itching (pruritus) at application site
- Folliculitis
- Hypopigmentation
- Hypertrichosis (increased hair growth)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Additive risk of local and systemic side effects. | Major |
| Topical Immunosuppressants (e.g., Tacrolimus, Pimecrolimus) | May be used sequentially but concurrent use on same area not recommended; increased risk of infection. | Moderate |
| CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin) | If systemically absorbed, metabolism of betamethasone may be reduced, increasing systemic exposure. | Moderate |
| Live Vaccines (e.g., BCG, MMR, Varicella) | Systemic immunosuppression from absorbed steroid may impair immune response and increase risk of vaccine-induced infection. | Major |
7. Patient Counselling
- DO use exactly as prescribed by your doctor.
- DO apply a thin layer only to the affected area.
- DO wash your hands before and after application (unless hands are being treated).
- DO inform your doctor if there is no improvement after 1-2 weeks.
- DON'T use it for longer than prescribed.
- DON'T apply to the face, groin, or armpits unless specifically instructed.
- DON'T cover the area with tight bandages or plastic wraps unless told to do so.
- DON'T use it to treat any skin condition other than the one it was prescribed for.
- DON'T let the cream/ointment come into contact with your eyes, mouth, or inside the nose.
8. Toxicology & Storage
Overdose: Topical: Severe local effects include intense skin atrophy, striae, ulceration, and signs of systemic absorption (Cushingoid features, adrenal suppression). Acute systemic overdose (from ingestion): Hyperglycemia, fluid and electrolyte disturbances, hypertension, myopathy, psychosis, peptic ulceration.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.